Page 4 - பால் க்ரெஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பால் க்ரெஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பால் க்ரெஸ் Today - Breaking & Trending Today

Invitation to MorphoSys' First Quarter Results Conference Call on May 6, 2021


Invitation to MorphoSys First Quarter Results Conference Call on May 6, 2021
DGAP-News: MorphoSys AG
/ Key word(s): Quarter Results
28.04.2021 / 22:00
Conference Call Alert
Invitation to MorphoSys First Quarter Results Conference Call on May 6, 2021
 
MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, will publish its results for the first quarter of 2021 on May 5, 2021 at 10:00pm CEST (4:00pm EDT).
MorphoSys Management Board will host a conference call and webcast on May 6, 2021 at 2:00pm CEST (8:00am EDT) to present the first quarter and first 3-month financial results 2021 and provide an outlook for 2021. ....

United Kingdom , Jean Paul Kress , Roland Wandeler , Janssen Biotech Inc , Drug Administration , Janssen Research Development , Research Development , Morphosys Us Inc , Distribution Services , Exchange Commission , Quarter Results , Morphosy First Quarter Results Conference Call , Prime Standard Segment , Management Board , Board Members , Paul Kress , Chief Executive , Chief Financial , Chief Operating , Chief Research , Janssen Research , Janssen Biotech , Morphosy Annual Report , Corporate News , Regulatory Announcements , ஒன்றுபட்டது கிஂக்டம் ,

MorphoSys AG: Invitation to MorphoSys' Full Year Results 2020 Conference Call on March 16, 2021


MorphoSys AG: Invitation to MorphoSys Full Year Results 2020 Conference Call on March 16, 2021
Conference Call Alert
PLANEGG & MUNICH, GERMANY / ACCESSWIRE / March 9, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein, and peptide technologies, will publish its results for the financial year 2020 on March 15, 2021 at 10:00 pm CET (5:00 pm EDT).
MorphoSys Management team will host a conference call and webcast on March 16, 2021 at 2:00 pm CET (9:00 am EDT) to present results for the financial year 2020 and provide an outlook for 2021.
The conference call will start with a presentation by the Management team followed by a Q&A session. Presenters will be: ....

United Kingdom , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Jeanette Bressi , Roland Wandeler , Janssen Biotech Inc , Drug Administration , Janssen Research Development , Research Development , Morphosys Us Inc , Us Communications , Exchange Commission , Conference Call , Prime Standard Segment , Paul Kress , Chief Executive , Chief Financial , Chief Operating , Chief Research , Janssen Research , Janssen Biotech , Morphosy Annual Report , ஒன்றுபட்டது கிஂக்டம் , ஜீன் பால் க்ரெஸ் ,